What is Generico?
Generico operates within the healthcare sector, with a specific focus on making medicines affordable and accessible. The company's mission is to educate the Indian population on the advantages of generic medications, thereby enhancing healthcare accessibility for all individuals. Their services are tailored to meet the needs of the general public seeking cost-effective pharmaceutical options, positioning Generico as a key player in democratizing healthcare access.
How much funding has Generico raised?
Generico has raised a total of $2.9M across 3 funding rounds:
Other Financing Round
$1.4M
Series A
$136K
Debt
$1.4M
Other Financing Round (2020): $1.4M with participation from Alteria Capital
Series A (2021): $136K led by Alteria Capital
Debt (2021): $1.4M supported by Alteria Capital
Key Investors in Generico
Alteria Capital
Alteria Capital is a prominent investment firm, likely specializing in providing significant debt and equity financing to growing companies, as evidenced by their participation in multiple funding rounds for Generico.
Alteria Capital
Alteria Capital's continued involvement suggests a strong belief in Generico's business model and its potential for scaling within the healthcare market.
Alteria Capital
As a key financial backer, Alteria Capital's strategic investments are crucial for Generico's expansion and its mission to improve medicine accessibility.
What's next for Generico?
The substantial enterprise-level capital infusion, highlighted by the recent strategic investment, positions Generico for accelerated expansion and market penetration. This financial backing is expected to fuel advancements in their service offerings, potentially including broader geographic reach within India and enhanced educational outreach programs. Generico's trajectory suggests a move towards solidifying its role as a leader in the affordable generic medicine market, leveraging this capital to scale operations and deepen its impact on public health.
See full Generico company page
